II Using this Guideline

Purpose and objectives
This guideline concerns hysterectomy performed in patients with benign diseases. It aims to examine the entire range of surgical procedures as well as the associated context in order to permit optimal treatment of women in each case. The guideline presents and evaluates the individual indication areas, describes the hysterectomy routes, evaluates the advantages and disadvantages of individual surgical techniques and presents possible alternatives. The guideline aims to provide a basis that women can use to obtain in-depth information in order to make a decision about the treatment plan in consultation with their doctor based on their knowledge of the advantages and disadvantages of the specific procedure and of the effects of the operation on their quality of life. In these times of increasing cost pressure in the health care system, it is also essential to include this aspect in the considerations.
Targeted patients
Patients with an equivocal indication for hysterectomy and patients who have undergone a hysterectomy.
Target audience
The guideline addresses members of the health care profession involved in performing this surgical procedure. A medical background is required to understand this guideline.
This guideline is aimed at the following groups of people: " gynecologists in private practice " gynecologists working in a clinical setting " nursing professionals " the cooperating partners of the medical profession (e.g. health care professionals, payers) " the patients concerned and their personal setting (partners, etc.) " the general public, in order to provide it with information about sound medical approaches
Period of validity
The validity of this guideline was confirmed by the chairpersons/ heads of the participating medical societies/organizations/associations and by the head of the DGGG and the DGGG Guideline Commission in April 2015, thereby also confirming the entire contents of the guideline. This guideline is valid until April 30, 2020. This period of validity was estimated based on the contents of the guideline. If need be, the guideline can be updated before it has expired; if the guideline is still considered to represent the current state of knowledge, its period of validity can be extended.
III Guideline
1 Methodology
Principles
The methodology for the compilation of this guideline is prescribed by the classification assigned to the guideline. The AWMF Guidance Manual and Rules for Guideline Development (Version 1.0) sets out the rules for classifying guidelines. Guidelines are differentiated into lowest (S1), moderate (S2) and highest (S3) class. The lowest class of guideline is defined as consisting of a set of recommendations for action compiled by a non-representative group of experts. In 2004 the S2 class was divided into two subclasses: S2e (evidence-based) and S2k (consensus-based). The highest class (S3) combines both approaches. This guideline is classified as S3.
Literature search
The following literature databases were searched: " Cochrane Menstrual Disorders and Subfertility Group specialized register of controlled trials " Central " MEDLINE " Embase " Biological Abstracts " The National Research Register The following keywords were used for the search:
complications " quality of life The search encompassed the period from January 1990 to November 2011. In addition, MEDLINE was specifically searched with regard to certain questions. In order to achieve a transparent and up-to-date evidence base, an updated literature search was performed in MEDLINE (via PubMed) in 2013-2014 on the following topics: " comparison of hysterectomy routes " comparison of hysterectomy to uterine artery embolization or myomectomy for symptomatic uterine fibroids " comparison of hysterectomy and drug therapy for uterine fibroids, dysfunctional menstrual disorders or adenomyosis. The results of the literature search were included in the current version of the guideline.
1.3
Evidence tables
Evidence grading based on the Oxford Centre for Evidence-Based Medicine levels of evidence To evaluate the evidence (levels 1 to 5), the Oxford Centre for Evidence-Based Medicine classification system was used in its most recent version published in 2009 as Level of Evidence (LoE).
Recommendation grading
Pure evidence grading of a guideline at S2e/S3 level based on the Oxford classification can be translated into a grade of recommendation (GR) for a guideline. This symbolic recommendation level is divided into three gradations with various degrees of linguistic expression (l " Table 2 ).
The classification of "Recommendations" presented above corresponds to both the evaluation of evidence and the clinical relevance of the studies on which they are based and their scope/factors not listed in the grading of the evidence, such as the selection of patient cohort, intention-to-treat or per-protocol outcome analyses, medical or ethical action toward the patient, countryspecific applicability, etc. Conversely, a strong, moderate or weak level of evidence can lead to strong, regular or open recommendations in a related linear fashion. The only level that permits both an upward and downward classification is the moderate evidence level, in which a translation into level A or level 0 is possible. In special exceptional cases, converting the highest evidence level into the weakest/an open recommendation or vice versa must be explained in the background text. " Strong evidence level → Grade A or Grade B recommendation " Moderate evidence level → Grade A or Grade B or Grade 0 recommendation " Weak evidence level → Grade B or Grade 0 recommendation
Statements
If statements by specialists are included in this guideline that are not intended as recommendations for action, but rather simply for the purpose of presentation, these are referred to as "statements". For these statements, it is not possible to indicate evidence levels.
Consensus strength
As part of a structured consensus agreement process (S2k/S3 level), the eligible participants at the meeting agree on the statements and recommendations that were drawn up. During this process, significant modifications to the wording may occur. Subsequently, the consensus strength is determined based on the number of participants (l " Table 3 ).
Expert consensus Introduction
All of the sections below are excerpts from the long version of the guideline and do not claim to be complete. Only the sections of the long version are mentioned that contain consensus-and/or evidence-based statements or recommendations. Sections without these particulars are described briefly at most. To obtain more information (background texts, additional literature citations) on existing sections or sections not listed here, please download the long version (see Guideline documents).
Indications and contraindications 3.1 Indications
Common indications for performing hysterectomy for benign diseases include the following: uterine fibroids, menstrual disorders, adenomyosis of the uterus, endometriosis, uterine prolapse and precancerous lesions of the endometrium and the cervix.
The numbers in Germany were as follows in 2012: uterine fibroids: 60.7 %, prolapse: 27.9 %, menstrual problems: 25.2 %, hyperplasia and atypia of the endometrium or cervix: 2.9, and endometriosis: 15.1 % of cases [1] . Due to the comorbidities, a total of nearly 130 % is reached. This also reflects clinical reality, in which the histologically ascertainable findings of uterine fibroids, adenomyosis and endometriosis often coincide. The clinical picture of "menstrual problems" as an umbrella term encompasses hypermenorrhea, dysmenorrhea and dyspareunia. For this reason, it is often difficult to list and code a single diagnosis as the indication for hysterectomy. This overlapping also means that experts may disagree about the treatment plan to be used in a particular case. Thus, when indicating surgery for these conditions, personal experience, especially the mastery of a certain surgical technique or with the use of alternatives, plays a significantly greater role than for cancer, for example, for which treatment is based on a single hard diagnosis. Due to this special situation, it is particular important to inform the patient about the range of treatment options, about the recommended procedure, the associated risks and to clearly point out the advantages and disadvantages of each surgical technique that can be expected and if the merits of techniques "compete with" each other. Ultimately, the decision as to whether hysterectomy is indicated, as well as on using alternative methods, must be made by an informed patient along with her attending physician. For this reason, the term "informed consent and shared decision-making" has become established. 
Hysterectomy for uterine fibroids
and 3.6 Cytological suspicion of endometrial and glandular precancers
Consensus-based recommendation 3.E10 Microscopically confirmed CIN alone, regardless of severity, is not an indication for hysterectomy.
In the case of persistent HPV detection after conization alone, hysterectomy must not be performed.
If there is a cytological or microscopic diagnosis of an adenocarcinoma in situ (AIS) of the cervix, conization with endocervical curettage of the high cervical canal must be performed (not a primary hysterectomy) in order to rule out an invasive adenocarcinoma.
If there is a cytological or microscopic diagnosis of an adenocarcinoma in situ (AIS) of the cervix, a primary hysterectomy must not be performed in order to rule out an invasive adenocarcinoma. Instead, conization with endocervical curettage of the high cervical canal must be performed. Hysterectomy may be performed after conization in the case of residual recurrent CIN 2/3 or glandular neoplasia located in the low cervical canal. (expert consensus) Consensus strength (+++) Literature: These recommendations were adopted in the expert consensus based on the S2 Guidelines for HPV infection/pre-invasive lesions of the female genitals: Prevention, Diagnosis and Treatment [9] .
3.7
Atypical endometrial hyperplasia in the histology of the aspiration or of the curettage material [16, 17] and endometrial ablation [18] Information and consent Preoperative information and consent includes the following: " the indication and objective of the procedure including an assessment of the probability of success " presentation of options for treatment/methods, including nonsurgical alternatives " explanation of the preferred method " description of procedure-related risks and typical complications, including their sequelae " information about patient behavior before and after the procedure. 
Consensus
Perioperative management
Hysterectomy is a procedure that generally involves the same steps regardless of the indication. For this reason, for quality-related (and forensic) reasons, every hospital is advised to develop standards for perioperative management based on the current evidence. Perioperative checklists are recommended to prevent errors and ensure patient safety [19] [20] [21] [22] [23] [24] .
Preoperative management
Consensus-based recommendation 5.E19 For patients with known or suspected organic or systemic disorders, the relevant laboratory parameters (e.g. for patients with bleeding disorders) must be determined. (expert consensus) Consensus strength (+++)
Intraoperative management
Evidence-based recommendation 6.E20 Prophylactic antibiotics must be administered prior to hysterectomy. (LoE Oxford 2009 1a, GR A) Consensus strength (+++) Literature: [25] 
Postoperative management
Evidence-based recommendation 6.E21 Perioperatively, risk-adapted thromboembolic prophylaxis must be administered. (LoE Oxford 2009 1a, GR A) Consensus strength (+++) Literature: [26] 7 Surgical techniques 7.1
Vaginal hysterectomy
In addition to the general indication for a hysterectomy, the use of a vaginal approach involves the following special aspects: " To ensure that the approach is reliable, the uterus must be sufficiently mobile. In general, with the patient under anesthesia, it should be possible to pull the portio to at least the mid-vagina. The vagina must be sufficiently broad and elastic for the surgery to be performed safely. In case of doubt, it may be helpful to perform the pelvic examination under anesthesia by pulling on the portio using bullet forceps. " In the case of suspected extrauterine pathology prior to surgery, for instance, in the adnexa, a laparoscopically assisted or abdominal approach should be favored.
" A vaginal approach is therefore particularly suitable for benign uterine diseases such as uterine prolapse. For nulliparous women and postmenopausal patients with atrophied vaginas and patients with long, narrow vaginas (obese patients) and patients with massively enlarged uteruses, the vaginal approach has its limits. " However, the size of the uterus can be overcome by using morcellation or hemisection. As a rule of thumb, again depending on the sufficient breadth of access and the mobility of the organ, vaginal hysterectomy can be performed for a uterine size of around a 12-week pregnancy or a uterine weight of around 250 to 300 g. This corresponds to an average diameter of the uterine body of around 8 to 10 cm [27] . On the other hand, much larger uteruses can also be delivered safely using a vaginal approach [28] . " If a patient has already had a Cesarean section or undergone other pelvic surgery, vaginal hysterectomy can be much more difficult and the risk of injuring the bladder is increased. In this case, the situation must be taken into consideration when indicating vaginal hysterectomy. " In the case of suspected or confirmed uterine or ovarian malignancy, a purely vaginal procedure should not be the primary choice. Selected patients with microinvasive cervical cancer or endometrial cancer are exceptions [29] .
Laparoscopically assisted vaginal hysterectomy (LAVH)
Laparoscopically assisted vaginal hysterectomy (LAVH) combines laparoscopic and vaginal surgical techniques. The use of laparoscopy intends to avoid abdominal hysterectomy and enable vaginal hysterectomy. The laparoscopic part of the procedure includes all of the steps that cannot be performed vaginally or that can only be performed with a great deal of difficulty or increased risk (adhesiolysis, excision of endometriotic nodules, adenectomy, detachment of the adnexa from the uterus). During LAVH, dissection in the area of the broad ligament of the uterus and the parametria ends above the uterine artery, which is detached from the vaginal side. The uterus is extracted through the vagina and if needed, hemiotomy or morcellation is carried out. No specific contraindications applying only to LAVH are known. If laparoscopy is contraindicated in general, a purely vaginal or abdominal approach must be considered.
Total laparoscopic hysterectomy (TLH)
With total laparoscopic hysterectomy (TLH), all steps of the procedure are performed laparoscopically. In contrast to LAVH, the dissection of the uterine artery is performed laparoscopically, as is the paracervical dissection up to the vagina, the detachment of the uterus from the vagina and the closure of the vagina by means of laparoscopic suturing. There is no switch from an abdominal to a vaginal approach. Due to the dissection, in particular in the area of the cervix, TLH must be learned as a separate surgical procedure, even by surgeons with laparoscopic experience [30] . For this reason, systematic reviews [31] report about elevated rates of complications, especially in the area of the urogenital tract, as well as increased risk of bleeding and relatively long operation times and recommend that this surgical procedure should be considered as a secondary choice. However, at centers with extensive TLH experience these problems have largely been resolved [30, 32] . Therefore, if there is sufficient experience with the technique, its complication rate is similar to that of other lap-aroscopic surgical procedures. It appears that the operating time is longer than the operating time for vaginal hysterectomy and LAVH [31] . This is confirmed by the metaanalysis conducted by Gendy et al. [33] . However, the metaanalysis also confirmed that with the inclusion of 5 randomized controlled trials (RCTs) there were no differences with respect to complication rates (LoE 2a, level decreased due to high heterogeneity of the study results and signs of publication bias). Several publications report postoperative dehiscences of the vaginal cuff in contrast to other modes of hysterectomy [34] [35] [36] . This is attributed to the high frequency surgical detachment of the uterus from the vagina, whereby the endoscopic suturing technique is also discussed. A randomized study of vaginal stump suturing techniques comparing vaginal and laparoscopic approaches by an experienced surgeon did not yield any differences [37] .
Laparoscopic supracervical hysterectomy (LASH)
LASH constitutes an alternative to abdominal, total vaginal and total laparoscopic hysterectomy. In 2010, supracervical hysterectomy was performed in 13.5 % of cases in Germany, most of them using a laparoscopic approach [1] . In the United States, 2% of all hysterectomies are performed supracervically, while in Scandinavia, around 36 % of all hysterectomies are performed as supracervical hysterectomies [38] .
With LASH, the first steps are performed similar to the procedure for LAVH and TLH and involve exposure of the site and dissection of possible associated pathologies (adhesions, endometriosis, adnexal abnormalities). Laparoscopic dissection ends at the level of the uterovesical fold. The uterus is detached supracervically and after intraabdominal morcellation is removed via the trocar. LASH is a procedure with a low complication rate [39] [40] [41] . Detaching the uterine body from the cervix at the level of the isthmus means that surgery in the area of the parametria and dissection of the bladder is required to only a limited extent, if at all. The complications reported for TLH, such as urinary tract lesions or dissection-related bleeding, are therefore rare for LASH.
Abdominal hysterectomy
In addition to the general indication for a hysterectomy, the use of the abdominal approach involves the following special aspects: " In addition to oncological indications, the size of the uterus and associated disorders such as endometriosis or extensive adhesions resulting from previous surgery are indications for abdominal hysterectomy. " An abdominal approach is also indicated depending on the individual situation in patients with a long, narrow vagina, for nulliparous women and patients with comorbidities and in patients for whom a vaginal or laparoscopic approach does not appear to be possible or would be associated with an increased complication risk. In case of doubt, when deciding whether abdominal hysterectomy is indicated, it may be helpful to perform the pelvic examination under anesthesia by pulling on the portio using bullet forceps.
Robot-assisted hysterectomy
Robot-assisted surgical procedures are used to a limited extent for treating gynecological and obstetrics patients. They are often indicated in patients with cancer. Robot-assisted hysterectomy can be implemented and can be performed quickly by a surgeon with laparoscopic experience [42, 43] . Since the expenses and the operating time are far greater than those for conventional laparoscopy, in view of the limited resources, the use of robot-assisted hysterectomy must be decided on a case-by-case basis [44] [45] [46] [47] . Systematic overview articles on robot-assisted hysterectomy ( [46] [LoE 1b]). The interpretation of both RCTs showed differences in operating times. No differences were observed with regard to complications (blood loss, "minor" or "major" complications or postoperative use of pain medication).
With regard to quality of life, Sarlos et al.
without blindingobserved improvements in some aspects of quality of life after 3 weeks and after 6 to 8 weeks, while Paraiso et al. did not observe any differences after 6 months. In both studies, the operating time for robot-assisted hysterectomy was significantly longer than for laparoscopic surgery, with Paraiso observing an average longer time of 70 minutes and Sarlos reporting 20 minutes longer. The length of hospital stay did not differ. A systematic review of robot-assisted hysterectomy with a single site port [52] found only retrospective series or case studies with a median operating time of 109 minutes. No information on transfusions was reported (LoE 3). No information on complications or follow-up was reported. The procedure must still be considered to be experimental.
Intraoperative and postoperative complications (l " 
Documentation
Every patient chart created for a patient undergoing a hysterectomy must include the indication, the symptoms and the findings of the patient. These comprise the general and specific history, especially previous illnesses and operations, as well as the general and gynecological examination results including imaging results.
Checklists have proven helpful for perioperative documentation. The surgical report lists the date, diagnosis and summary of the treatment plan, along with the names of the physicians involved. The surgical report serves as a description of the surgical procedure and the findings observed during surgery. In the case of an uncomplicated hysterectomy, this description may be brief. A surgical report becomes particularly important, however, if complications occur. It is recommended to clearly describe in the primary report any special anatomic circumstances and other conditions giving rise to complications. At critical points, such as in the case of parametric bleeding, the surgeon should state that he or she checked the ureter by means of inspection, palpation or exposure and acted properly and carefully.
The postoperative course must also be documented. The scope and results of a physical examination should be listed in the form of notes accompanied by the time of day. The same procedure should be used for findings from other hospitals and institutes. The discharge summary is also very important.
10
Comparison of methods
In recent years, numerous publications and two systematic reviews have compared methods. 
11.2
Hysterectomy and incontinence
If a patient for whom a hysterectomy is indicated is to undergo surgery for stress incontinence at the same time, the hysterectomy may be performed using the most straightforward procedure. The stress incontinence surgery does not impact the method used for hysterectomy.
Obstetric hysterectomy for postpartum hemorrhage
Consensus-based recommendation 11.E27 For postpartum, life-threatening uterine bleeding and the failure of alternative treatment options, a hysterectomy is indicated as a last resort and in the event of a life-threatening situation. (expert consensus) Consensus strength (+++) 12 Quality of life Evidence-based recommendation 12.E28 Patients should be informed that after they have undergone an indicated hysterectomy, they can generally expect to experience improvement in quality of life and sexual functioning compared to their preoperative situation. (LoE Oxford 2009 1a, GR B) Literature: [60] [61] [62] [63] Evidence-based statement 12.S11 A prophylactic bilateral adnexectomy may be associated with undesired long-term adverse effects and requires separate information and consent. (LoE Oxford 2009 1a) Consensus strength (++) Literature: [64, 65] 13 Algorithm: Alternatives to hysterectomy (l " Figs. 1 to 3) 
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